This federal Project Grant award, titled "EICOSANOIDS, CHRONIC KIDNEY DISEASE PROGRESSION, AND ASSOCIATED CARDIOVASCULAR RISK," was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847).
The $892,433 award to Cedars-Sinai Medical Center will fund research to better understand how upstream eicosanoid pathways contribute to the development of chronic kidney disease (CKD) and associated cardiovascular risk, especially in the early stages of disease progression. The project aims to comprehensively investigate the components of inflammatory activity related to CKD and cardiovascular outcomes across the disease spectrum. This work is expected to pave the way for future studies evaluating anti-inflammatory therapies, including existing and novel agents, for modulating eicosanoid variation and improving cardiorenal outcomes.
Generated 3/4/25, 8:13 AM